These include the model’s limited clinical relevance to human stroke patients, possible variability of results due to differences in surgical techniques and anesthesia, unclear mechanisms by which Dlg4 provides neuroprotection, and a lack of evaluation of potential effects beyond the brain. This evidence concerns the gene DLG4 and Stroke.